News

Museveni Launches Clinical Trials for UBV-01N Covid-19 Drug, Pledges Better Pay for Scientists

2 Mins read


President Yoweri Museveni has today launched Uganda’s first Clinical Trials for UBV-01N, a home grown Natural Covid-19 treatment drug product innovated and developed by Ugandan Scientists in collaboration with the Ministry of Health Uganda, Makerere University School of Public Health and Mulago Hospital among other stakeholders.

As a major breakthrough in the fight against the Corona Virus, the President congratulated the Ugandan scientists involved in the innovation, pledging to prioritise scientists in his next term of office.

The President said that Ugandans must work towards building an independent Uganda, which does not depend on outsiders.

“We shall not accept dependency. You must build an independent Uganda. We are working on the vaccine and treatment by ourselves,” he said.

Speaking at the launch, Museveni said that it is now time for Uganda to build the capacity of self-dependency for its scientists and stop running to foreigners for help all the time.

He congratulated Ugandan scientists for coming up with the treatment for Covid-19, which he says will bring smiles to Ugandan patients.

“This term of office, one of my seven priorities will be to ensure that scientists are well paid. Even if we don’t have money, our scientists must get enough pay,” he said.

Museveni arriving at Mulago hospital for the launch.

The President warned against the un-necessary procurement procedures and corruption tendencies for such very important and urgent procurement cases.

“There are some parasites doing business in the name of procurements but also a lot of corruption in the so called financial controls. The law of procurement should only work for beans but not serious procurement like this one,” Museveni said.

President Yoweri Kaguta Museveni [centre] together with First Lady and Minister of Education and Sport Hon. Janet Kataha with the Head of Scientists Makerere, Dr. Nambatya Grace and Dr.Bruce Kilenga at the launch of the COVID-19 Clinical trails Vaccine at Mulago Hospital, on 27th January 2021. Photo by, Nayebare Joan, PPU.

Since March 2020, Uganda has been battling COVID-19. There are 39,188 confirmed COVID-19 cases, with 433 active cases and 318 deaths. To date, there is no confirmed COVID-19 treatment.

The Minister of Health Hon. Dr Jane Ruth Aceng said that the trial will also validate content standardization, and replication after which, it will be rolled out for industrial production and wide spread use.

“The product has already gone through quality assurance steps and got all the necessary certificates and approval for use in human beings. The product has been approved by the National Drug Authority (NDA), Uganda National Bureau of Standards and National Council of Science and Technology,” Dr. Aceng said.

Dr. Jane Ruth Acheng revealed that the findings and the outcome of the studies that they are doing and continue to do, will be shared with the whole nation from time to time. She commended the President and Ugandans who have been observing the Covid-19 SOPs.

“I want to thank President Museveni for observing Standard Operating Procedures (SOPs) before, during and after his campaigns. That was as great of you as a leader,” she said.

Vice Chancellor Makerere University, Barnabas Nawangwe

The presidential advisor on epidemics, Dr. Monica Musenero, said that the group has worked with the Natural Chemotherapeutic Research Institute (NCRI) to produce Natural chemotherapeutic products to treat viral and bacterial infections.

“I want to thank the team and we are looking forward to more innovative natural products that will make the country proud,” Dr. Musenero said.



Source – ChimpReports

Power your brain with Ugandan News

Add some text to explain benefits of
subscripton on your services.

Leave a Reply

Your email address will not be published. Required fields are marked *